BACKGROUND: Few data are available on time-related changes in use and outcomes of invasive procedures after acute myocardial infarction in very elderly patients. Our objective was to describe trends in revascularization procedures and outcomes in a provincial cohort of very elderly patients who had experienced acute myocardial infarction. METHODS: We used a database of hospital discharge summaries to identify all patients aged 80 years or older admitted for acute myocardial infarction in Quebec. We used the provincial database of physicians' services and medication claims to assess treatment and obtain data on survival. RESULTS: Between March 1996 and March 2007, 29 750 patients aged 80 years or older were admitted to hospital for acute myocardial infarction. During this period, use of percutaneous coronary interventions increased from 2.2% to 24.9%, and use of coronary artery bypass graft surgery increased from 0.8% to 3.1%. Evidence-based prescriptions of medication increased over time (p < 0.001). The prevalence of reported comorbidities was higher during the period of 2003-2006 than during the 1996-1999 period. One-year mortality improved over time (46.5% for 1996-1999 v. 40.9% for 2003-2006, p < 0.001) but remained unchanged in the subgroup of patients who did not undergo revascularization. INTERPRETATION: The use of revascularization, especially percutaneous coronary interventions, in the very elderly after acute myocardial infarction has been growing at a rapid pace, while the prevalence of reported comorbidities has been increasing in this population. Revascularization procedures are no longer restricted to younger patients. In the context of an aging population, it is imperative to determine whether these changes in practice are cost-effective.
BACKGROUND: Few data are available on time-related changes in use and outcomes of invasive procedures after acute myocardial infarction in very elderly patients. Our objective was to describe trends in revascularization procedures and outcomes in a provincial cohort of very elderly patients who had experienced acute myocardial infarction. METHODS: We used a database of hospital discharge summaries to identify all patients aged 80 years or older admitted for acute myocardial infarction in Quebec. We used the provincial database of physicians' services and medication claims to assess treatment and obtain data on survival. RESULTS: Between March 1996 and March 2007, 29 750 patients aged 80 years or older were admitted to hospital for acute myocardial infarction. During this period, use of percutaneous coronary interventions increased from 2.2% to 24.9%, and use of coronary artery bypass graft surgery increased from 0.8% to 3.1%. Evidence-based prescriptions of medication increased over time (p < 0.001). The prevalence of reported comorbidities was higher during the period of 2003-2006 than during the 1996-1999 period. One-year mortality improved over time (46.5% for 1996-1999 v. 40.9% for 2003-2006, p < 0.001) but remained unchanged in the subgroup of patients who did not undergo revascularization. INTERPRETATION: The use of revascularization, especially percutaneous coronary interventions, in the very elderly after acute myocardial infarction has been growing at a rapid pace, while the prevalence of reported comorbidities has been increasing in this population. Revascularization procedures are no longer restricted to younger patients. In the context of an aging population, it is imperative to determine whether these changes in practice are cost-effective.
Authors: Menko-Jan de Boer; Jan-Paul Ottervanger; Arnoud W J van 't Hof; Jan C A Hoorntje; Harry Suryapranata; Felix Zijlstra Journal: J Am Coll Cardiol Date: 2002-06-05 Impact factor: 24.094
Authors: Eric D Peterson; Karen P Alexander; David J Malenka; Edward L Hannan; Gerald T O'Conner; Ben D McCallister; William S Weintraub; Fred L Grover Journal: Am Heart J Date: 2004-09 Impact factor: 4.749
Authors: Richard G Bach; Christopher P Cannon; William S Weintraub; Peter M DiBattiste; Laura A Demopoulos; H Vernon Anderson; Paul T DeLucca; Elizabeth M Mahoney; Sabina A Murphy; Eugene Braunwald Journal: Ann Intern Med Date: 2004-08-03 Impact factor: 25.391
Authors: Ilan Goldenberg; Shlomi Matetzky; Amir Halkin; Arie Roth; Elio Di Segni; Dov Freimark; Dan Elian; Oren Agranat; Yedael Har Zahav; Victor Guetta; Hanoch Hod Journal: Am Heart J Date: 2003-05 Impact factor: 4.749
Authors: G W Stone; C L Grines; K F Browne; J Marco; D Rothbaum; J O'Keefe; G O Hartzler; P Overlie; B Donohue; N Chelliah Journal: J Am Coll Cardiol Date: 1995-02 Impact factor: 24.094
Authors: John A Dodson; Judith S Hochman; Matthew T Roe; Anita Y Chen; Sarwat I Chaudhry; Stuart Katz; Hua Zhong; Martha J Radford; Jacob A Udell; Akshay Bagai; Gregg C Fonarow; Martha Gulati; Jonathan R Enriquez; Kirk N Garratt; Karen P Alexander Journal: JACC Cardiovasc Interv Date: 2018-11-26 Impact factor: 11.195
Authors: Jonathan Afilalo; Karen P Alexander; Michael J Mack; Mathew S Maurer; Philip Green; Larry A Allen; Jeffrey J Popma; Luigi Ferrucci; Daniel E Forman Journal: J Am Coll Cardiol Date: 2013-11-27 Impact factor: 24.094
Authors: Eleonore V Grant; Jenny Summapund; Daniel D Matlock; Victoria Vaughan Dickson; Sohah Iqbal; Sonal Patel; Stuart D Katz; Sarwat I Chaudhry; John A Dodson Journal: Med Decis Making Date: 2020-04 Impact factor: 2.583